NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against FTAI Aviation Ltd. (NASDAQ:FTAI) and certain of its senior executives for potential violations of the federal securities laws. If you invested in FTAI Aviation, you are encouraged […]
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Crocs, Inc. (NASDAQ:CROX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Crocs, you are encouraged to
https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities, including call options, of Five9, Inc. (NASDAQ: FIVN) between June 4, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. So what: If you purchased Five9 securities during the Class
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") (NASDAQ:NVO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=125410&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
"The Quantum Almanac: 2025-2026" Details Encryption Collapse Timelines, Practical PQC Roadmaps, and Qryptonic’s Proven Solutions NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / A startling 99% of Fortune 500 firms face crippling vulnerability when Q-Day arrives-the moment quantum computers can break classical encryption. The Quantum Almanac: 2025-2026, now exclusively available in
The following issues have been halted by CIRO: Company: Medexus Pharmaceuticals Inc. TSX Symbol: MDP All Issues: Yes Reason: Pending News Halt Time (ET): 03:33 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and
https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofMarqeta, Inc. (NASDAQ: MQ) between May 7, 2024 and November 4, 2024, both dates inclusive (the “Class Period”), of the important February 7, 2025 lead plaintiff deadlinein the securities class action first filed by the Firm. So what: If you
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Symbotic Inc. (NASDAQ:SYM) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Symbotic, you are encouraged